Navigation Links
New device detects deadly lung disease
Date:7/23/2014

A scientist from the University of Exeter has developed a simple, cheap and highly accurate device for diagnosing a frequently fatal lung disease which attacks immune deficient individuals such as cancer patients and bone marrow transplant recipients.

The lateral-flow device (LFD), created by Professor Chris Thornton, detects invasive pulmonary aspergillosis, a notoriously difficult to diagnose disease caused by the fungus Aspergillus.

Invasive aspergillosis is a leading cause of death in acute leukaemia and bone marrow transplant patients, accounting for more than 200,000 life-threatening infections each year, with an associated mortality rate of up to 90%.

The new device which resembles a pregnancy test but uses a small blood sample will cost health authorities just 10 per test and will fit into routine hospital practices. It will potentially reduce the high rates of mortality and morbidity associated with the disease and enable better use of costly and toxic antifungal drugs.

Professor Thornton, of Biosciences, said: "Individuals with invasive pulmonary aspergillosis are often suffering from complex medical conditions and the symptoms, which include raised temperature, breathlessness, chest pain and fatigue, could be attributable to a number of other conditions. At present, it can take several days to identify the disease correctly due to the lack of accurate diagnostic tests, and the patient's health deteriorates significantly in the absence of appropriate treatment.

"The low cost, speed, ease-of-use and compatibility of the new device with standard hospital procedures means that the disease can be quickly and accurately monitored at the point-of-care using a simple blood test or with fluids collected during lung biopsy."

Professor Thornton and colleagues have published a number of clinical studies with hospitals in London, Germany, Austria and elsewhere in mainland Europe.

There is also an ongoing trial with leukaemia patients at the Royal Devon and Exeter Hospital under the care of Consultant Haematologist Dr Paul Kerr. He said: "We at the Exeter Leukaemia Unit are very proud to work with Dr Thornton and his team on this project; diagnosing this life-threatening infection is very difficult, and can involve either subjecting the patient to unpleasant and potentially dangerous investigations, or can result in the use of expensive and toxic medication that may not always be needed. It is very exciting to think that a simple laboratory test may allow us to greatly simplify this process in the future."

With financial support from the University and Angel funders, a spin-out company called ISCA Diagnostics Ltd was established to enable commercialisation of the test. Global marketing and distribution of the device is delivered through ISCA's partner company OLM Medical.

The lateral flow device will be being used in hospitals around the world from August. The test uses a highly specific monoclonal antibody to detect a diagnostic marker of active Aspergillus infection, meaning that doctors can more precisely identify patients developing the disease.

This success is a visible example of how University bench-to-bedside Research & Development can deliver commercial impact through academic, industry and private investor partnerships.

The work has received funding from the US National Institutes of Health, HEIF, private investors, and a global pharmaceuticals company.

Professor Thornton is a fungal immunologist with a specialist interest in hybridoma technology and immunodiagnostics. His recent research has concentrated on human infections by opportunistic fungal pathogens and their rapid detection using monoclonal antibodies.


'/>"/>

Contact: Eleanor Gaskarth
e.f.gaskarth@exeter.ac.uk
44-782-730-9332
University of Exeter
Source:Eurekalert  

Related medicine news :

1. Cardiovascular Prosthetic Devices Market in North America to 2020 Report Available at MarketOptimizer.org
2. InventHelp Inventor Develops Versatile Medical Testing Device (OCC-760)
3. Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc.
4. Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw
5. Medical Devices Market in India 2014 Trends and Analysis in Study Available at MarketReportsOnline.com
6. US Weight Loss Surgery Devices Market (Bariatric Surgery) Forecasts to 2020 New Report Available at ReportsnReports.com
7. FDAnews Announces Device Software Verification and Validation: Get Ready for a New Breed of Investigators, On-Demand Webinar, Aug. 12, 2014
8. United States Gynecological Devices Market to 2020 Forecasts Report Available at ReportsnReports.com
9. Global Electrodes for Medical Devices Market: Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
10. Europe Cardiac Surgery Device Market Value to Go Beyond USD 3.4 Bn by 2020, According to iData Research Study Available at MarketPublishers.com
11. Reha Technology Launches the Armotion™, a Device for the Rehabilitation of the Upper Extremity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New device detects deadly lung disease
(Date:2/13/2016)... ... February 13, 2016 , ... DDi , a Makro ... list for its expertise in eClinical Solutions. DDi has built its solution competency ... needs of global clients. DDi provides smarter technology for Clinical Development, Regulatory and ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed ... top students from U.S. universities who will draw from Siemens’ deep knowledge ...
(Date:2/12/2016)... ... , ... Each year, the American Physical Therapy Association (APTA) offers a Combined ... Convention Center. Almost 10,000 physical therapists across the country are expected to attend this ... their chosen field and network with their colleagues. As in years past, HydroWorx ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare ... San Francisco General Hospital on April 5-7. The series is a multi-day, multi-workshop ... habits. The workshops cover a broad range of topics, including coaching skills, the ...
(Date:2/12/2016)... ... February 12, 2016 , ... AssureVest Insurance Group, a locally owned ... charity drive that will raise funds earmarked to purchase computers and software for Mrs. ... , “My school is in a low-income area and has more than 60 2nd ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
(Date:2/11/2016)... 11, 2016  Walgreens has committed to provide drug ... Washington, D.C. as part of a ... commended by shareholder advocacy organization As You Sow. ... "Many people hold on to unneeded drugs because they lack ... consequences." --> Conrad MacKerron , Senior Vice ...
(Date:2/11/2016)... Feb. 11, 2016  MiMedx Group, Inc. (NASDAQ: ... amniotic membrane and other birth tissues, human skin and ... and market advanced products and therapies, announced today that ... Global Healthcare Conference in New York ... Michael J. Senken , Chief Financial Officer and ...
Breaking Medicine Technology: